World Bank bars Famy Care, Olive Healthcare from receiving its contractsPost published:August 5, 2017Post category:Industry NewsA World Bank investigation has found that pharma firms Famy Care and Olive Healthcare engaged in ‘fraud’ and ‘misconduct’ Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostDigital transactions gain momentum, shows RBI data Next PostONGC buys 80% participating interest in GSPC block You Might Also Like Mitsubishi Electric announces investment in Akribis Systems August 7, 2019 Is Your Collaborative Robot as Safe as You Think? May 7, 2019 The market that Reliance Jio seeks to tap July 25, 2017